| Study title |
A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects with Nonalcoholic Steatohepatitis and Fibrosis |
| Disease or condition |
NASH-Nonalcoholic Steatohepatitis |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
Saroglitazar Magnesium or Placebo |
| Phase |
2b |
| Study site |
Carolinas Medical Center, Center for Liver Disease and Transplant (Atrium Health) |
| Study location |
Charlotte, NC |
| Principal investigator name and email |
Andrew deLemos, andrew.delemos@atriumhealth.org |
| Study coordinator name and email |
Marina Sycheva, marina.sycheva@atriumhealth.org |
| Phone Contact |
704-446-4835 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT05011305 |
